Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer

• 收藏
• 分享

专利权人:

HYBRIGENICS SA.

发明人:

Susan Benjamin,Cécile Planquette,Rémi Delansorne

申请号：

US15655394

公开号：

US10478497B2

申请日:

2017.07.20

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention concerns combinations of inecalcitol with an anti-CD38 agent such as daratumumab, MOR 202 or isatuximab for the treatment of cancer, such as hematological malignancies by increasing or inducing the expression of CD-38 by inecalcitol.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/